CN116322704A - 使用呋塞米的治疗方法 - Google Patents

使用呋塞米的治疗方法 Download PDF

Info

Publication number
CN116322704A
CN116322704A CN202180052186.3A CN202180052186A CN116322704A CN 116322704 A CN116322704 A CN 116322704A CN 202180052186 A CN202180052186 A CN 202180052186A CN 116322704 A CN116322704 A CN 116322704A
Authority
CN
China
Prior art keywords
hour
administration
adult
furosemide
complete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180052186.3A
Other languages
English (en)
Chinese (zh)
Inventor
J·F·莫尔
J·塔克尔
M·哈斯曼
E·M·佩科雷利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ScPharmaceuticals Inc
Original Assignee
ScPharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ScPharmaceuticals Inc filed Critical ScPharmaceuticals Inc
Publication of CN116322704A publication Critical patent/CN116322704A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CN202180052186.3A 2020-08-05 2021-08-05 使用呋塞米的治疗方法 Pending CN116322704A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061518P 2020-08-05 2020-08-05
US63/061,518 2020-08-05
PCT/US2021/044723 WO2022031959A1 (en) 2020-08-05 2021-08-05 Methods of treatment using furosemide

Publications (1)

Publication Number Publication Date
CN116322704A true CN116322704A (zh) 2023-06-23

Family

ID=77774970

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180052186.3A Pending CN116322704A (zh) 2020-08-05 2021-08-05 使用呋塞米的治疗方法

Country Status (9)

Country Link
US (1) US20230270759A1 (https=)
EP (2) EP4192473B1 (https=)
JP (1) JP7844438B2 (https=)
CN (1) CN116322704A (https=)
AU (1) AU2021320308A1 (https=)
CA (1) CA3190585A1 (https=)
IL (1) IL300152A (https=)
MX (1) MX2023001385A (https=)
WO (1) WO2022031959A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024512650A (ja) * 2021-04-02 2024-03-19 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下注入
EP4648761A1 (en) * 2023-01-09 2025-11-19 scPharmaceuticals Inc. Methods of treatment using loop diuretics

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160051507A1 (en) * 2013-04-05 2016-02-25 Scpharmaceuticals Inc. Pharmaceutical Formulations for Subcutaneous Administration of Furosemide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595961B2 (en) * 2001-04-16 2003-07-22 Becton, Dickinson And Company Sterilizable transfer or storage device for medicaments, drugs and vaccines
ES3041602T3 (en) * 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160051507A1 (en) * 2013-04-05 2016-02-25 Scpharmaceuticals Inc. Pharmaceutical Formulations for Subcutaneous Administration of Furosemide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DOMENIC A. SICA, MD, ET AL: ""Subcutaneous Furosemide in Heart Failure Pharmacokinetic Characteristics of a Newly Buffered Solution"", 《J A C C : BAS I C TO TRANS L A T I O NAL S C I E N CE》, vol. 3, no. 1, 28 February 2018 (2018-02-28), pages 25 - 34 *
DOMENIC A. SICA, MD, ET AL: ""Subcutaneous Furosemide in Heart Failure Pharmacokinetic Characteristics of aNewly Buffered Solution"", 《J A C C : BAS I C TO TRANS L A T I O NAL S C I E N CE》, vol. 3, no. 1, 28 February 2018 (2018-02-28), pages 25 - 34 *

Also Published As

Publication number Publication date
MX2023001385A (es) 2023-03-03
EP4192473A1 (en) 2023-06-14
EP4681736A2 (en) 2026-01-21
IL300152A (en) 2023-03-01
JP2023536730A (ja) 2023-08-29
EP4681736A3 (en) 2026-03-25
US20230270759A1 (en) 2023-08-31
EP4192473B1 (en) 2025-12-03
CA3190585A1 (en) 2022-02-10
JP7844438B2 (ja) 2026-04-13
AU2021320308A1 (en) 2023-03-02
WO2022031959A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
JP7738696B2 (ja) フロセミドの濃縮液体医薬製剤及びそれを投与する方法
CN116322704A (zh) 使用呋塞米的治疗方法
KR20260035797A (ko) 루프 이뇨제를 사용한 치료 방법
JP2025530593A (ja) ループ利尿薬の液体医薬製剤及びそれを投与する方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination